Monthly Lectures
Below is information about past CERSI monthly lectures. Additional information and resources will be published as soon as available.
View All FDA CERSI Lecture Info
2020 Lecture Series:
| February 12, 2020 | Steven Jay, University of Maryland Fischell Department of Bioengineering (M-CERSI) "Tackling Challenges of Extracellular Vesicle-Based Therapeutic Development" |
2019 Lecture Series:
| March 19, 2019 | Bruce Yu, University of Maryland School of Pharmacy (M-CERSI) "Nondestructive Analytics for Biologics and Continuous Biomanufacturing" |
2018 Lecture Series:
| March 7, 2018 | Yu Chen, University of Maryland Fischell Deptartment of Bioengineering (M-CERSI) "Near-infrared Fluorescence Imaging: A Tool for Enhancing Visualization of Biological Structures" |
2017 Lecture Series:
| December 14, 2017 | Victor Montori, Mayo Clinic "Patient Understanding of Medical Products: Shared-Decision Making and FDA Policy" |
| November 3, 2017 |
Harlan Krumholz, Yale University School of Medicine
"HuGO: A Novel Smartphone-Based Mobile Health Platform"
|
| December 14, 2017 | Victor Montori, Mayo Clinic "Patient Understanding of Medical Products: Shared-Decision Making and FDA Policy" |
| November 3, 2017 |
Harlan Krumholz, Yale University School of Medicine
"HuGO: A Novel Smartphone-Based Mobile Health Platform"
|
| October 3, 2017 | Kannan Rangaramanujam, JHU CERSI "Systemic, Targeted Nanotherapies for Neurological Disorders" |
| September 14, 2017 |
Laura Esserman, UCSF-Stanford CERSI
"Breast Cancer Oncology: One Source Project"
|
| June 26, 2017 | David Smith, University of Maryland (M-CERSI) "Role and Revevance of Proton-Coupled Oligopeptide Transporters in the Brain" |
| June 6, 2017 |
Kathryn Sandbert, Georgetown University CERSI
"Sex Differences and Vascular Disease: Presentation, Diagnostics and Treatment"
|
| May 11, 2017 | Steve Goodman, UCSF-Stanford CERSI "Reproducibility in Medicine and Science" |
| April 13, 2017 |
Monica McArthur, University of Maryland CERSI (M-CERSI)
|
| March 14, 2017 | Peter Doshi, University of Maryland CERSI (M-CERSI) “Ensuring Accuracy of Clinical Trial Publications” |
| February 9, 2017 |
Nitish Thakor, Ph.D., Johns Hopkins University
"Neuroprosthetics and Brain Machine Interface: Innovation to Implementation"
|
| January 19, 2017 | Ray Dorsey, M.D., MBA, University of Rochester Medical Center "Telemedicine: The Future of Clinical Trials" |
2016 Lecture Series:
| December 8, 2016 | Joe Wu, UCSF-Stanford CERSI “Stem Cells Biology” |
| November 30, 2016 |
Chris Re, UCSF-Stanford CERSI
"Deep Dive Knowledge Management”
|
| October 26, 2016 | Steve Quake, UCSF-Stanford CERSI “Genomic Based Diagnostics” |
| September 20, 2016(406) |
Louis Weiner, MD, Georgetown CERSI
"Antibody-Targeted Cancer Immunotherapy”
|
| June 21, 2016 (190) | Evan Mayo-Wilson JHU CERSI “Measuring Harms that Matter to Patients in Clinical Trials's” |
| May 17, 2016(165) |
Michael Fischbach UCSF-Stanford CERSI
“Gut Microbiome and Health Diseases”
|
| April 19, 2016 (175) | John Bridges JHU CERSI “An Introduction to the Art and Science of Measuring Patient and Caregiver Preferences” |
| March 15, 2016 (87) |
Esteban G. Burchard, MD, MPH, Professor, Department of Bioengineering & Therapeutic Sciences and Medicine, University of California, San Francisco
“Making Precision Medicine Socially Precise”
|
| February 16, 2016 (164) | G. Elliott Cook, PharmD, BCPS, Chief Pharmacist, Provider Resources, Inc. “Measuring the Impact of FDA Communication Alerts and Re-Alerts” |
| January 19, 2016 (291) |
Michael Stoto, Ph.D., Professor, Health Systems Administration and Population Health, University of Georgetown
“Drug Safety Meta-Analysis: Promises and Pitfalls”
|
2015 Lecture Series:
| November 17, 2015 (86) | Dr. Jose Jalife, M.D, Director, Center for Arrhythmia Research, University of Michigan “Human Heart in the Dish: Novel In Vitro Cardiotoxicity Testing Platform” |
| October 20, 2015 (26) | Myong-Hee Sung, Ph.D., Staff Scientist, Center for Cancer Research, National Cancer Institute "Systems Biology of Cell Signaling and Drug Responses through Modeling and Microscopy" |
| April 14, 2015 (186) | Donald Berry, Ph.D., University of Texas, MD Anderson Cancer Center “Clinical Trial Design: Bayesian Approaches and Simulations” |
| December 9, 2014 (38) | Rose Blackburne, M.D., MBA, Global Head, Medical Delivery Solutions, Interim North America Head "Oncology Therapeutic Strategy & Medical Delivery Therapeutic Delivery Unit" |
2014 Lecture Series:
| November 18, 2014 (70) | John Michael Sauer, Ph.D., Executive Director, Predictive Safety Testing Consortium (PSTC) Critical Path Institute “Building a Translational Safety Strategy: An Overview of Nonclinical and Clinical Biomarker Qualification Efforts in the Predictive Safety Testing Consortium (PSTC)” |
| November 12, 2014 (67) | David Pisetsky, M.D., PhD, Executive Director, Predictive Safety Testing “The Immune Properties of Natural and Synthetic DNA” |
| October 15, 2014 (29) | Eytan Ruppin, Ph.D., Professor, School of Computer Science & Sackler Faculty of Medicine “Identifying Novel Selective Cancer Drug Targets” |
| September 12, 2014 (145) | Lori Herz, Ph.D., Lehigh University, Bethlehem PA “Shortages of Injectable Drugs: CMC-Related Causes and Potential Solutions” |
| June 18, 2014 (100) | Arthur Atkinson Jr., M.D, M.A.C.P., Feinberg School of Medicine, Northwestern University “Pharmacokinetic Studies in Patients with Impaired Renal Function” |
| May 28, 2014 (128) | Ruth Day, Ph.D., Duke University Durham, North Carolina “Enhanced Formats for Drug Information: Effects on Attention Comprehension and Memory” |
| May 14, 2014 (22) | Susan dosReis, Ph.D., University of Maryland Baltimore “Antipsychotic Treatment Patterns and Dosing in Pediatric Foster Care: Does Outpatient Treatment Conform with the Evidence-Base?” |
| April 7, 2014 (36) | Julie Zito, University of Maryland School of Pharmacy “Antipsychotic Use Patterns in Medicaid-insured Youth in California: Variations by Region and Race/ethnicity” |
| March 3, 2014 | Julie Zito, University of Maryland School of Pharmacy “Antipsychotic Use Patterns in Medicaid-insured Youth in California: Variations by Region and Race/ethnicity” ** Postponed due to weather ** |
| February 19, 2014 (137) | Richard Kim, M.D., University of Western Ontario, Canada “Clinical and Pharmacogenomic Predictors of Statin Disposition and Response” |
| January 24, 2014 (32) | Michael Zachariah, Ph.D., University of Maryland Dept. of Chemistry and Biochemistry “Characterization of Nano-biomaterials with Electrospray Differential Mobility Analysis” |
2013 Lecture Series:
| December 3, 2013 (54) | David R. Goodlett, Ph.D., University of Maryland School of Pharmacy Baltimore “Novel Applications/Methods of Mass Spectrometry (MS) in Drug and Biologic R & D” |
| Nov. 25, 2013 (42) | Gregory Payne, PhD University of Maryland Fischell Dept. of Bioengineering Topic to be determined |
| Oct. 21, 2013 (141) | Diane Jorkasky, M.D., F.A.C.P., CMO of Complexa Therapeutics “A Clinician’s Journey to Enlightenment” (or how I got exposed to exposure) |
| July 22, 2013 (16) | Don DeVoe, PhD University of Maryland Mechanical Engineering Dept. “Microfluidic-Enabled Liposomes for Targeted Drug Delivery” |
| June 27, 2013 (64) | Vence Bonham, J.D. National Institute of Health Education and Community “Reducing Racial and Ethnic Health Disparities: Is Genomic Medicine the Path?" |
| May 3, 2013 (86) | Curtis Klaassen, Ph.D., University of Kansas Medical Center “New and Future Mechanisms of Hepatotoxicity” |
| April 10, 2013 (121) | David Greenblatt, M.D. , Tufts University of Medicine and Tufts Medical Center “Drug Interactions with Fruit Beverages and Natural Products: Mechanisms and Consequences” |
| March 25, 2013 | Vence Bonham, J.D., National Institute of Health-Education and Community “Reducing Racial and Ethnic Health Disparities: Is Genomic Medicine the Path?” **Postponed due to weather** |
| Feb. 28, 2013 (45) | Peter Sorger, Ph.D., Harvard Medical School “Measuring and Modeling Oncogenic Networks and Drugs that Target Them” |
| Feb. 11, 2013 (74) | Anjan Nan, Ph.D., University of Baltimore Dept. of Pharmaceutical Science “Nanotechnology and Drug Delivery” |
| Jan. 28, 2013 (53) | Stephen Thomas, Ph.D., University of Maryland School of Public Health “Accelerating 4th Generation Disparities Research to Achieve Health Equity” |
2012 Lecture Series:
| Dec. 10, 2012 (59) | John Fisher, Ph.D., University of Maryland Fischell Dept. of Bioengineering “Bone Tissue Engineering with Biomaterials and Bioreactors” |
| Nov. 27, 2012 (57) | Peggy Compton, Ph.D., Georgetown Univ. School of Nursing & Health Studies “Opioid-induced Hyperalgsai” |
| Oct. 30, 2012 | Anjan Nan, Ph.D., University of Baltimore Dept. of Pharmaceutical Science “Nanotechnology and Drug Delivery” **Postponed due to weather** |
| Aug. 27, 2012 (68) | William Bentley, Ph.D., University of Maryland Fischell Dept. of Bioengineering “Biofabrication: An Assemble Paradigm for Device Construction the Facilitates Communication” |
| July 23, 2012 (64) | Yu Chen, Ph.D., University of Maryland Fischell Dept. of Bioengineering “Novel OCT Imaging and Sensing Devices for Clinical Translation” |
| June 21, 2012 (80) | Annette Stemhagen, Ph.D., United Bio Source Corporation “The Role of Patient-Provider Agreements in the Context of Risk Evaluation and Mitigation Strategies with Emphasis on Opids” |
| April 19, 2012 (67) | Vadivel Ganapathy, Ph.D., Georgia Health Sciences “Inhibition of the Amino Acid Transporter SLC6A14 to Treat Cancer” |
| UMD Total Attendance: |
2,664 Attendance; 149 CE Credits Earned; 35 Lectures
|
Top